Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current and future pharmacological treatment for overactive bladder.

Naoki Yoshimura1, Michael B Chancellor

  • 1Department of Urology, University of Pittsburgh School of Medicine, Pennsylvania, USA.

The Journal of Urology
|October 24, 2002
PubMed
Summary

New treatments for urinary incontinence and overactive bladder focus on advanced drug delivery and modulating nerve function. Future therapies like gene therapy show promise for improved efficacy and patient compliance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The genitourinary phenotype of COVID: a personal perspective.

International urology and nephrology·2026
Same author

Senescence-Driven Inflammation and Immune Dynamics in the Progression of Radiation Cystitis.

Cells·2026
Same author

Safety and Efficacy of LP-10 Liposomal Tacrolimus in Oral Lichen Planus: A Multicenter Phase 2 Trial.

Dermatology and therapy·2025
Same author

Advancing Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Diagnosis: A Comparative Analysis of Machine Learning Methodologies.

Diagnostics (Basel, Switzerland)·2024
Same author

Rationale for the Use of Topical Calcineurin Inhibitors in the Management of Oral Lichen Planus and Mucosal Inflammatory Diseases.

Cureus·2024
Same author

Iltamiocel Autologous Cell Therapy for the Treatment of Female Stress Urinary Incontinence: A Double-Blind, Randomized, Stratified, Placebo-Controlled Trial.

Neurourology and urodynamics·2024

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Urinary incontinence and overactive bladder are prevalent conditions often overlooked in general medicine.
  • Effective management strategies are crucial for improving patient quality of life.

Purpose of the Study:

  • To review the scope and impact of urinary incontinence and overactive bladder.
  • To discuss current and emerging pharmacotherapies for these conditions.

Main Methods:

  • Focused on pharmacological bladder therapies, including existing agents and drugs in development.
  • Examined central nervous system targets (e.g., duloxetine) and intravesical therapies (e.g., capsaicin, botulinum toxin).
  • Emphasized modulating bladder afferent nerve function for overactive bladder prevention.

Main Results:

Related Experiment Videos

  • Advanced drug delivery systems offer enhanced efficacy, reduced side effects, and better patient compliance.
  • Gene therapy presents a promising future avenue for treating genitourinary conditions via minimally invasive techniques.

Conclusions:

  • Conventional anticholinergic treatments for urinary incontinence and overactive bladder have limitations.
  • Future research prioritizing afferent nerve intervention holds significant potential for managing voiding dysfunction.